HALISTER1: INDIA RATINGS: Bafna Pharmaceuticals, GKC Projects Cut

INDIA RATINGS: Bafna Pharmaceuticals, GKC Projects Cut

(Bloomberg) -- Here’s a roundup of Indian co. debt-rating changes.
  • To get this story sent to your inbox real-time, run NI INRATINGS , click on Display & Edit, then Set Alert Delivery
DOWNGRADES
  • Bafna Pharmaceuticals
    • Long-term rating cut to D from Crisil
    • Cites delays in servicing term loan obligations in November and December
  • GKC Projects
    • LT rating cut to D from BB- at ICRA
    • Cites delays in debt servicing by company
Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
BFNA IN (Bafna Pharmaceuticals Ltd)

To de-activate this alert, click here

UUID: 7947283